President Donald Trump signed an executive order on Oct. 19, 2026, creating a new Women’s Health Division within the National Institutes of Health (NIH) and a White House task force to coordinate women’s health research. The announcement puts a fresh federal spotlight on research gaps, but the order does not set a specific funding target.
What the order establishes
The Department of Health and Human Services says NIH must establish the division within 90 days. A separate White House task force is intended to align federal agencies and research priorities. Its co-chairs are Health Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles.
Research areas named
The initiative spans women’s health across the lifespan. Areas listed by HHS include cardiovascular disease, cancer, autoimmune and inflammatory conditions, chronic pain, endometriosis, uterine fibroids, polycystic ovary syndrome, infertility, maternal health, menopause, Alzheimer’s disease and osteoporosis.
What remains unclear
The executive action creates an organizational structure and directs coordination; it does not guarantee a new amount of research funding. The Associated Press reported that the order sets no specific funding goals. NIH already had an Office of Research on Women’s Health, established in 1990, so the newly announced division will sit within an existing federal research landscape. Implementation details and future appropriations will determine the practical effect.
Why it matters: Better representation in clinical and biomedical research can help researchers understand how conditions and treatments affect women. The key measure will be whether the new structure leads to sustained, transparent research priorities and resources.
Sources: U.S. Department of Health and Human Services; Associated Press; Reuters.
.jpg){kind=link}